Navigation Links
Health Plans Reduce Administrative Expenses with HEALTHsuite(R) from RAM Technologies, Inc.
Date:9/18/2009

FORT WASHINGTON, Pa., Sept. 18 /PRNewswire/ -- Today's economic conditions coupled with the anticipated impacts of health insurance reform are forcing health plans to find ways to reduce expenses. RAM Technologies, Inc., a leading developer of software applications for health care payers, enables health plans to reduce expenses with the cost saving features of their health care administrative solution suite HEALTHsuite(R) and eHealthsuite(TM).

HEALTHsuite and eHealthsuite offer quantifiable processes to reduce operating costs while improving performance and service levels for health plans:

  • Powerful EDI capabilities coupled with a superior claim adjudication engine foster a "Paperless" claim processing environment and first pass auto-adjudication rates in excess of 80%
  • Robust Internet self-service portals available 24 x 7 dramatically reducing demands on customer support personnel
  • Advanced Subrogation and Overpayment Recovery capabilities
  • Configurable claim auditing and cost containment capabilities
  • And more...

"With the federal government considering the imposition of constraints on health plan spending and profits, it is more important than ever to control expenses," states Robert A. Tulio, President of RAM Technologies. "HEALTHsuite and eHealthsuite offer tangible features to reduce operating costs while increasing productivity of the health plan."

About RAM Technologies, Inc.

RAM Technologies is a leading developer of enterprise wide healthcare administrative solutions for payers. For over 28 years RAM Technologies has created superior system solutions for health plans supporting Medicare, Medicaid, Commercial and Federal Health Programs. The implementation of HEALTHsuite and eHealthsuite(TM) from RAM Technologies enables clients to achieve drama
'/>"/>

SOURCE RAM Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... (May 22, 2012) Pushed to the brink of ... into an ancient system that has helped organisms cope ... As an integral part of this system, heat ... malignant cells accommodate the genetic changes and profound disturbances ... Researchers have theorized that inhibiting HSP90 just might render ...
(Date:5/22/2012)... to quit smoking during pregnancy can significantly improve ... Vitamin C daily, according to a new study ... Hospital. , "Smoking during pregnancy is known to ... baby, causing lifelong decreased lung function and an ... M.C.R., neonatologist and associate professor of pediatrics at ...
(Date:5/22/2012)... TUESDAY, May 22 (HealthDay News) -- The number of ... 2006, a new study finds. Researchers said one ... cardiac death has become more commonplace, and many of ... the organs aren,t healthy enough to attempt a transplant. ... due to a condition known as fatty liver disease, ...
(Date:5/22/2012)... UC Davis have developed a microfluidic chip to test ... cheaper, faster and more reliable than current testing for ... gives results in real time," said Ying Liu, a ... UC Davis Department of Biomedical Engineering. , The team ... in China and the United States. , About one-third ...
(Date:5/22/2012)... have identified novel biomarkers that could be used to ... people potentially exposed to unknown and variable doses for ... are published in the May 1 issue of ... of surgery, biochemistry, pharmacology and toxicology at the Medical ... study. , There is an urgent need for rapid, ...
Breaking Medicine News(10 mins):Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3Health News:Vitamin C improves lung function in newborns of pregnant smoking women 2Health News:U.S. Liver Transplants Declining 2Health News:New TB test promises to be cheap and fast 2
... the time pancreatic cancer is discovered, it is often late stage ... are low. Dr. Aaron Chevinsky, a surgical oncologist specializing in ... and has created a groundbreaking team approach to improve communication among ... ...
... Alternatives International, Inc. ("NAI") (Nasdaq: NAII ... customized nutritional supplements, today announced that effective December ... with NAI ended.NAI also announced it completed certain ... Bank. Among other changes the amendments extend ...
... Tenn., Jan. 7 Ambulatory Services of America,Inc. ... LLC, its seventh,radiation oncology joint venture. ROSA ... Coast Cancer Center - Gulf Shores, P.C., Monroeville ... P.C., and ASA,s,subsidiary, Radiation Oncology Services of America, ...
... Hanger Orthopedic Group, Inc. (NYSE: HGR ) ... operations for the year ended December 31, 2008, on Tuesday, ... announcing the results for the year ended December 31, 2008 ... market. The conference call is scheduled to begin at 9:00 ...
... low levels would work for ER patients with hypoxia ... Going to the world,s most elevated natural laboratory, Mount ... rules about the amount of oxygen needed by a ... can tolerate extremely low levels of oxygen, much lower ...
... 73 Percent Increase in Patients Unable to Pay Out-of-Pocket ... ERsSACRAMENTO, Calif., Jan. 7 The ... impact on California,s community hospitals, according to a newly ... The report, which is based on a survey conducted ...
Other Medicine News:Health News:Nationally-Recognized Pancreatic Cancer Surgeon Develops Unique Team Approach to Improve Patient Outcomes 2Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:Ambulatory Services of America, Inc. Announces Joint Venture with Gulf Coast Cancer Centers 2Health News:Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call 2Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Economic Downturn Takes Toll on California Hospitals 2
(Date:5/22/2012)... May 22, 2012 Sorbent Therapeutics, Inc. ... renal diseases, presented positive data from its Phase ... of 111 heart failure patients with chronic kidney ... as compared to placebo.    Data ... presented in an oral session at the Annual ...
(Date:5/22/2012)... 22, 2012   AMRI (NASDAQ: ... organization, announced today the appointment of Ian Shott as ... chairman, president and CEO. In this newly created role, ... in Europe, including the company,s site in Wales, United ... team. As the founder of Excelsyn, acquired by AMRI ...
(Date:5/22/2012)... Inc. and AB SCIEX announced today that they have ... Dr. Gary Van Berkel and his colleagues of Oak ... innovator in the field of mass spectrometry and is ... the field.  The agreement provides Prosolia a license to ... based on the liquid micro- junction surface sampling probe ...
Breaking Medicine Technology:Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 3AMRI Announces President for AMRI Europe 2AMRI Announces President for AMRI Europe 3Prosolia and AB SCIEX reach licensing agreement 2Obese Drivers Less Likely to Buckle Up 3A Study 90693 1Obese Drivers Less Likely to Buckle Up 3A Study 90693 2HPV vaccine completion rate among girls is poor getting worse 90691 1HPV vaccine completion rate among girls is poor getting worse 90691 2HPV vaccine completion rate among girls is poor getting worse 90691 3New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease 25324 1New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease 25324 2
... Ill., March 29, 2007 /PRNewswire-FirstCall/ -- Baxter,International Inc. ... investigational pandemic H5N1 influenza vaccine and,plans to initiate ... in Europe to confirm the study results. , ... candidate,vaccine is highly immunogenic at low doses, and ...
... Valortim-Treated,Animals , PRINCETON, N.J. and ANNAPOLIS, MD., ... a leading monoclonal antibody company, and,PharmAthene, Inc., ... development of biodefense countermeasures, today announced,that Valortim, ... developed for the prevention and treatment of ...
Other Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7
Angled 30 degree shaft. 13 mm from tip to bend with 2.5 mm hook curved tip. Polished finished. Overall length excluding hub: 35 mm, 1.4 inches....
Binkhorst, length 18 mm....
Army/Navy retractor (set of 2)....
Sharp. 4 mm wide. Hand-Held...
Medicine Products: